279 related articles for article (PubMed ID: 22935090)
1. Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines.
Kan AA; de Jager W; de Wit M; Heijnen C; van Zuiden M; Ferrier C; van Rijen P; Gosselaar P; Hessel E; van Nieuwenhuizen O; de Graan PN
J Neuroinflammation; 2012 Aug; 9():207. PubMed ID: 22935090
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis.
Aulická S; Česká K; Šána J; Siegl F; Brichtová E; Ošlejšková H; Hermanová M; Hendrych M; Michu EP; Brázdil M; Slabý O; Nestrašil I
Epilepsy Res; 2022 Feb; 180():106858. PubMed ID: 35026708
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis.
Furukawa A; Kakita A; Chiba Y; Kitaura H; Fujii Y; Fukuda M; Kameyama S; Shimada A
Epilepsy Res; 2020 Dec; 168():106502. PubMed ID: 33197783
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response.
Kan AA; van Erp S; Derijck AA; de Wit M; Hessel EV; O'Duibhir E; de Jager W; Van Rijen PC; Gosselaar PH; de Graan PN; Pasterkamp RJ
Cell Mol Life Sci; 2012 Sep; 69(18):3127-45. PubMed ID: 22535415
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus.
Bencurova P; Baloun J; Musilova K; Radova L; Tichy B; Pail M; Zeman M; Brichtova E; Hermanova M; Pospisilova S; Mraz M; Brazdil M
Epilepsia; 2017 Oct; 58(10):1782-1793. PubMed ID: 28815576
[TBL] [Abstract][Full Text] [Related]
6. Brain expression of inflammatory mediators in Mesial Temporal Lobe Epilepsy patients.
Leal B; Chaves J; Carvalho C; Rangel R; Santos A; Bettencourt A; Lopes J; Ramalheira J; Silva BM; da Silva AM; Costa PP
J Neuroimmunol; 2017 Dec; 313():82-88. PubMed ID: 29153613
[TBL] [Abstract][Full Text] [Related]
7. The mTOR pathway is activated in glial cells in mesial temporal sclerosis.
Sosunov AA; Wu X; McGovern RA; Coughlin DG; Mikell CB; Goodman RR; McKhann GM
Epilepsia; 2012 Jun; 53 Suppl 1():78-86. PubMed ID: 22612812
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD4 and CD8 T cells expressing pro-inflammatory cytokines in a cohort of mesial temporal lobe epilepsy patients with hippocampal sclerosis.
Rosa DV; Rezende VB; Costa BS; Mudado F; Schütze M; Torres KC; Martins LC; Moreira-Filho CA; Miranda DM; Romano-Silva MA
Epilepsy Res; 2016 Feb; 120():1-6. PubMed ID: 26709876
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis.
Leal B; Chaves J; Carvalho C; Bettencourt A; Brito C; Boleixa D; Freitas J; Brás S; Lopes J; Ramalheira J; Costa PP; da Silva BM; da Silva AM
Int J Neurosci; 2018 Apr; 128(4):305-310. PubMed ID: 28675059
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of interleukin 17 in the cortex and hippocampus from patients with mesial temporal lobe epilepsy.
He JJ; Sun FJ; Wang Y; Luo XQ; Lei P; Zhou J; Zhu D; Li ZY; Yang H
J Neuroimmunol; 2016 Sep; 298():153-9. PubMed ID: 27609289
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1β Plays a Pivotal Role via the PI3K/Akt/mTOR Signaling Pathway in the Chronicity of Mesial Temporal Lobe Epilepsy.
Xiao Z; Peng J; Gan N; Arafat A; Yin F
Neuroimmunomodulation; 2016; 23(5-6):332-344. PubMed ID: 28395287
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy.
Khoshkhoo S; Wang Y; Chahine Y; Erson-Omay EZ; Robert SM; Kiziltug E; Damisah EC; Nelson-Williams C; Zhu G; Kong W; Huang AY; Stronge E; Phillips HW; Chhouk BH; Bizzotto S; Chen MH; Adikari TN; Ye Z; Witkowski T; Lai D; Lee N; Lokan J; Scheffer IE; Berkovic SF; Haider S; Hildebrand MS; Yang E; Gunel M; Lifton RP; Richardson RM; Blümcke I; Alexandrescu S; Huttner A; Heinzen EL; Zhu J; Poduri A; DeLanerolle N; Spencer DD; Lee EA; Walsh CA; Kahle KT
JAMA Neurol; 2023 Jun; 80(6):578-587. PubMed ID: 37126322
[TBL] [Abstract][Full Text] [Related]
13. Gamma Knife radiosurgery for recurrent or residual seizures after anterior temporal lobectomy in mesial temporal lobe epilepsy patients with hippocampal sclerosis: long-term follow-up results of more than 4 years.
Lee EM; Kang JK; Kim SJ; Hong SH; Ko TS; Lee SA; Lee DH; Lee JK
J Neurosurg; 2015 Dec; 123(6):1375-82. PubMed ID: 26162046
[TBL] [Abstract][Full Text] [Related]
14. Untargeted lipidomic analysis of human hippocampus for temporal lobe epilepsy with hippocampal sclerosis.
Zhang H; Ren P; Huang Y; Zeng W; Zhong K; Gao H; Cen X; Bu Q
Epilepsy Res; 2020 Mar; 161():106299. PubMed ID: 32105993
[TBL] [Abstract][Full Text] [Related]
15. Mesial temporal lobe epilepsy with hippocampal sclerosis is a network disorder with altered cortical hubs.
Jin SH; Jeong W; Chung CK
Epilepsia; 2015 May; 56(5):772-9. PubMed ID: 25809843
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of excitatory synaptic transmission in the hippocampus and anterior temporal lobe by cyclin dependent kinase 5 (Cdk5) in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS).
Banerjee J; Srivastava A; Sharma D; Dey S; Tripathi M; Sharma MC; Sarat Chandra P; Banerjee Dixit A
Neurosci Lett; 2021 Sep; 761():136096. PubMed ID: 34217817
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile suggests different mechanisms underlying sporadic and familial mesial temporal lobe epilepsy.
Maurer-Morelli CV; de Vasconcellos JF; Bruxel EM; Rocha CS; do Canto AM; Tedeschi H; Yasuda CL; Cendes F; Lopes-Cendes I
Exp Biol Med (Maywood); 2022 Dec; 247(24):2233-2250. PubMed ID: 36259630
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β plays a role in the pathogenesis of mesial temporal lobe epilepsy through the PI3K/Akt/mTOR signaling pathway in hippocampal neurons.
Xiao Z; Peng J; Yang L; Kong H; Yin F
J Neuroimmunol; 2015 May; 282():110-7. PubMed ID: 25903737
[TBL] [Abstract][Full Text] [Related]
19. Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22.
Guerra Leal B; Barros-Barbosa A; Ferreirinha F; Chaves J; Rangel R; Santos A; Carvalho C; Martins-Ferreira R; Samões R; Freitas J; Lopes J; Ramalheira J; Lobo MG; Martins da Silva A; Costa PP; Correia-de-Sá P
Front Cell Neurosci; 2022; 16():910662. PubMed ID: 35875355
[No Abstract] [Full Text] [Related]
20. Functional substrate for memory function differences between patients with left and right mesial temporal lobe epilepsy associated with hippocampal sclerosis.
Jin SH; Chung CK
Epilepsy Behav; 2015 Oct; 51():251-8. PubMed ID: 26300534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
